| 612 |
Peroxisome proliferator-activated receptor alpha activation leading to early life stage mortality via reduced adenosine triphosphate |
You Song |
BY-SA |
227: Activation, PPARα
|
947: Increase, Early Life Stage Mortality
|
|
|
| 613 |
Peroxisome proliferator-activated receptor alpha activation leading to early life stage mortality via increased reactive oxygen species production |
You Song |
BY-SA |
227: Activation, PPARα
|
947: Increase, Early Life Stage Mortality
|
|
|
| 614 |
Peroxisome proliferator-activated receptor alpha activation leading to early life stage mortality via reduced vascular endothelial growth factor |
You Song |
BY-SA |
227: Activation, PPARα
|
947: Increase, Early Life Stage Mortality
|
|
|
| 615 |
Suppression of Keap1 cysteine oxidation leading to liver inflammation |
Young Jun Kim |
All rights reserved |
2385: Suppression of Keap1 cysteine oxidation
|
902: Inflammation, Liver
|
|
|
| 616 |
organic UV filter and its Photoproducts reproductive toxicity pathways |
Nataraj Bojan |
All rights reserved |
2 MIEs
|
2391: Reduced fertility / fecundity
|
|
|
| 617 |
The adverse outcome pathway of vascular calcification |
Ruiyang Ding |
All rights reserved |
None
|
None
|
|
|
| 618 |
PPARgamma activation leads to a diminished vaccine response |
Léo SPORTES-MILOT |
BY-SA |
1028: Activation of specific nuclear receptors, PPAR-gamma activation
|
2397: Diminished vaccine response
|
|
|
| 619 |
Androgen receptor antagonism leads to delayed preputial seperation via reduced fibroblast growth factor in genital-tubercle tissues |
Travis Karschnik |
BY-SA |
26: Antagonism, Androgen receptor
|
2401: Male preputial separation, failed/delayed
|
|
|
| 620 |
The Adverse Outcome Pathway to Deposition of Energy Leading to Female Decreased Fertility |
Jessica D'Urbano |
All rights reserved |
None
|
None
|
|
|
| 621 |
NOX2 Driven Oxidative Stress-Induced α-Synuclein Radical Formation and Tau Nitration Leading to Neurodegeneration |
Tejasvi kumar |
Open for adoption |
None
|
None
|
|
|
| 622 |
Calcineurin inhibitor induced nephrotoxicity leading to kidney failure |
Kate Liang |
All rights reserved |
None
|
759: Increased, Kidney Failure
|
|
|
| 623 |
Activation, estrogen receptor alpha leads to persistent vaginal cornification via increased kisspeptin release |
John Frisch |
BY-SA |
1065: Activation, estrogen receptor alpha
|
2306: Persistent vaginal cornification
|
|
|
| 624 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via insulin resistance-associated mitochondrial dysfunction |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 625 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via insulin resistance-associated oxidative stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 626 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via insulin resistance-associated endoplasmic reticulum stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 627 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via lipogenesis-associated mitochondrial dysfunction |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 628 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via lipogenesis-associated oxidative stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 629 |
Increased 11β-Hydroxysteroid dehydrogenase type 1 activity leading to MASLD progression via lipogenesis-associated endoplasmic reticulum stress |
You Song |
BY-SA |
2410: Increase, 11β-Hydroxysteroid dehydrogenase type 1 activity
|
4 AOs
|
Under Development |
|
| 630 |
Decreased 11β-Hydroxysteroid dehydrogenase type 2 activity leading to MASLD progression via insulin resistance-associated mitochondrial dysfunction |
You Song |
BY-SA |
2409: Decrease, 11β-Hydroxysteroid dehydrogenase type 2 activity
|
None
|
Under Development |
|
| 631 |
Decreased thyroid hormone receptor beta transcriptional activity leading to MASLD progression via endoplasmic reticulum stress |
You Song |
BY-SA |
None
|
None
|
|
|
| 632 |
Increased adrenal glucocorticoid production leading to MASLD progression (3) |
You Song |
BY-SA |
None
|
None
|
|
|
| 633 |
Increased adrenal glucocorticoid production leading to MASLD progression (4) |
You Song |
BY-SA |
None
|
None
|
|
|
| 634 |
Increased adrenal glucocorticoid production leading to MASLD progression (5) |
You Song |
BY-SA |
None
|
None
|
|
|
| 635 |
Increased adrenal glucocorticoid production leading to MASLD progression (6) |
You Song |
BY-SA |
None
|
None
|
|
|